beta-endorphin and Nasal-Obstruction

beta-endorphin has been researched along with Nasal-Obstruction* in 1 studies

Other Studies

1 other study(ies) available for beta-endorphin and Nasal-Obstruction

ArticleYear
Effects of beta-endorphin on nasal allergic inflammation.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2002, Volume: 32, Issue:2

    Beta-endorphin is a derivative of pro-opiomelanocortin. Cells of the immune system can also synthesize and secrete beta-endorphin. Its concentration is increased during the allergic reaction and during stress. Increased reactivity during psychological stress of allergic subjects is also well known.. Is beta-endorphin one physiological link between stress and an exacerbation of the allergic reaction?. First, intranasal beta-endorphin challenges with subsequent lavages to determine histamine and albumin levels and measurements of nasal flow and resistance in dose-response and time course experiments were performed. Secondly, we examined whether beta-endorphin pre-treatment increased the antigen-induced release of histamine and albumin in nasal lavages and the clinical symptoms.. Exogenous beta-endorphin (100 pM-10 microM/mL) induced a dose-dependent increase in nasal symptoms in asymptomatic allergic subjects with rhinitis (n = 14) as well as in non-allergic controls (n = 10), but did not release any mediators into nasal secretion. However, comparing the antigen-evoked release of mediators into nasal secretions with that of a beta-endorphin pre-treated antigen challenge we could note a significant enhancement of human serum albumin influx (P < 0.05) and histamine liberation (P < 0.05) 10 min after antigen challenge compared with the allergen challenge alone, with also a correlation with the more pronounced decrease in nasal flow (P < 0.05).. These results suggest that beta-endorphin-induced increase in nasal congestion is mediated through direct neuroendocrine receptor activation independent of mast cell activation and that during the allergic reaction there is a beta-endorphin/mast cell interaction that enhances the mediator response to nasal allergen challenge.

    Topics: Administration, Inhalation; Adult; Allergens; Antigens; beta-Endorphin; Dose-Response Relationship, Drug; Female; Histamine Release; Humans; Male; Middle Aged; Nasal Cavity; Nasal Lavage Fluid; Nasal Obstruction; Reference Values; Rhinitis, Allergic, Perennial; Serum Albumin

2002